Gian Lifecare Ratios

Gian Lifecare Ltd Ratios

The Gian Lifecare Ltd Ratios page provides a complete fundamental analysis of Gian Lifecare Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Gian Lifecare Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Gian Lifecare Ltd (NSE: , BSE: 542918) is currently trading at ₹7.81, with a market capitalization of ₹81.49M. As a major player in the Health services sector and Medical/Nursing services industry, Gian Lifecare Ltd remains a key stock for fundamental analysis using Gian Lifecare Ltd Ratios.

Gian Lifecare Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Gian Lifecare Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Gian Lifecare Ltd Ratios.

Historically, the Gian Lifecare Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 6.09
• 2022: 16.54
• 2021: 9.83
• 2020: 3.15

The decline in Gian Lifecare Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Gian Lifecare Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.92.

Historical P/B trend:

• 2024: 0.92
• 2023: 1.31
• 2022: 1.16
• 2021: 3.06

Gian Lifecare Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Gian Lifecare Ltd P/S ratio currently stands at 2.99, an important part of Gian Lifecare Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2.99
• 2023: 1.98
• 2022: 1.54
• 2021: 2.78

The rising Gian Lifecare Ltd P/S ratio indicates improved revenue valuation by investors.

Gian Lifecare Ltd Price to Cash Flow Ratio (P/CF)

The Gian Lifecare Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 998.18.

Historical Gian Lifecare Ltd Price to Cash Flow Ratio:

• 2024: 998.18
• 2023: 28.09
• 2022: 7.07
• 2021: 7.25
• 2020: 2.23

The rising Gian Lifecare Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Gian Lifecare Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Gian Lifecare Ltd EV currently stands at ₹166.52M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 166.52M
• 2023: 241.89M
• 2022: 164M
• 2021: 426.36M

Gian Lifecare Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Gian Lifecare Ltd EV/EBITDA ratio is currently 17.47, a key metric in Gian Lifecare Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 17.47
• 2023: 3.93
• 2022: 8.87
• 2021: 7.02

Higher Gian Lifecare Ltd EV/EBITDA suggests premium valuation.

Gian Lifecare Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Gian Lifecare Ltd D/E ratio is currently 0.30, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.30
• 2023: 0.25
• 2022: 0.30
• 2021: 0.32

Gian Lifecare Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Gian Lifecare Ltd ROE currently stands at -0.19%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -0.19
• 2023: 24.15
• 2022: 7.30
• 2021: 36.92

Declining ROE indicates pressure on profitability.

Gian Lifecare Ltd Ratios Analysis Summary

The Gian Lifecare Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Gian Lifecare Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Gian Lifecare Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.